The second strategy is through targeting the regulation of p21 (CDKN1A) by NUP155, where such an interaction mediated by the deacetylase enzyme HDAC4 and methylation of rRNA by FTSJ1 could be modulated to confer improved p53 response against liver cancer progression. This evidence concerns the gene TP53 and liver cancer.